Sexual dysfunction and diabetes

被引:50
作者
Jackson, G [1 ]
机构
[1] St Thomas Hosp, Ctr Cardiothorac, London SE1 7EH, England
关键词
sexual dysfunction; treatment; diabetes;
D O I
10.1111/j.1368-5031.2004.00180.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erectile Dysfunction (ED) is common in men with diabetes. Diabetic men are three times as likely to develop ED as non-diabetic men. The cause is multifactoral, but most commonly reflects endothelial dysfunction and autonomic neuropathy. Diabetes and vascular disease often coexist and ED may be a marker for silent occlusive arterial disease, for which the patient should be screened. Many men still do not volunteer their problem, hence, routine questioning by health care professionals is an important part of the overall management because of the deleterious effect of ED on relationships, self-esteem and quality of life. Treatment is effective in the majority and all options should be considered, beginning with the much preferred oral phosphodiesterase type 5 inhibitors (sildenafil, tadalafil, vardenafil). Female Sexual Dysfunction or Disorder (FSD) is more difficult to define and specific studies in diabetics are limited. Problems with arousal, lubrication and orgasmic dysfunction occur, but the fatigue of diabetes may be influencing these complaints, and in general, psychological issues appear to predominate.
引用
收藏
页码:358 / 362
页数:5
相关论文
共 16 条
[1]   Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications [J].
Basson, R ;
Berman, J ;
Burnett, A ;
Derogatis, L ;
Ferguson, D ;
Fourcroy, J ;
Goldstein, I ;
Graziottin, A ;
Heiman, J ;
Laan, E ;
Leiblum, S ;
Padma-Nathan, H ;
Rosen, R ;
Segraves, K ;
Segraves, RT ;
Shabsigh, R ;
Sipski, M ;
Wagner, G ;
Whipple, B .
JOURNAL OF UROLOGY, 2000, 163 (03) :888-893
[2]   Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus [J].
Boulton, AJM ;
Selam, JL ;
Sweeney, M ;
Ziegler, D .
DIABETOLOGIA, 2001, 44 (10) :1296-1301
[3]   Optimizing the therapeutic approach of transurethral alprostadil [J].
Ekman, P ;
Sjögren, L ;
Englund, G ;
Persson, BE .
BJU INTERNATIONAL, 2000, 86 (01) :68-74
[4]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[5]  
FOGARI R, 2002, J HYPERTENS, V14, P27
[6]   Apomorphine SL (Uprima®):: preclinical and clinical experiences learned from the first central nervous system-acting ED drug [J].
Giuliano, F ;
Allard, J .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (Suppl 1) :S53-S56
[7]  
Jackson G, 2002, INT J CLIN PRACT, V56, P663
[8]   Vacuum construction and external erection devices in erectile dysfunction [J].
Levine, LA ;
Dimitriou, RJ .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (02) :335-+
[9]   Drug therapy: Erectile dysfunction. [J].
Lue, TF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) :1802-1813
[10]   Survey says patients expect little physician help on sex [J].
Marwick, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2173-2174